|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| (11) | Number of the document | 2855500 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13793955.9 |
| Date of filing the European patent application | 2013-05-23 | |
| (97) | Date of publication of the European application | 2015-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-01 |
| (46) | Date of publication of the claims translation | 2020-11-10 |
| (86) | Number | PCT/US2013/042532 |
| Date | 2013-05-23 |
| (87) | Number | WO 2013/177468 |
| Date | 2013-11-28 |
| (30) | Number | Date | Country code |
| 201261651539 P | 2012-05-24 | US |
| (72) |
CROOKE, Rosanne, M., US
GRAHAM, Mark, J., US
FREIER, Susan, M., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Būdai ir kompozicijos, skirti apolipoproteino (A) raiškos moduliacijai |
| METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN(A) EXPRESSION |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 13 | 289.00 EUR |
| 2026-05-23 |